Apriglave-MV3 Tablet SR
Marketer
Dwivsonchem Life Science
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Apriglave-MV3 Tablet SR
Diabetac-Duo SR tablets are anti-diabetic medications combining multiple agents to manage type 2 diabetes in adults. This medication helps regulate blood glucose. Diabetac-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels and potential complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular meals and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Apriglave-MV3 Tablet SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Apriglave-MV3 Tablet SR
Managing type 2 diabetes
Major Benefits of Apriglave-MV3 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Apriglave-MV3 Tablet SR on an empty stomach.
Common Side effects of Apriglave-MV3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Apriglave-MV3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglave-MV3 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Apriglave-MV3 Tablet SR works:
Apriglave-MV3 extended-release tablets contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Apriglave-MV3 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Apriglave-MV3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Apriglave-MV3 tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Apriglave-MV3 Tablet SR is inadvisable for individuals with kidney impairment and should be avoided. Medical advice is recommended. Specifically, patients exhibiting severe kidney disease should not use Apriglave-MV3 Tablet SR.
LiverCAUTION
Patients with liver impairment should use Apriglave-MV3 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Apriglave-MV3 Tablet SR :
Should you forget to take your Apriglave-MV3 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Apriglave-MV3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



